Morgan Stanley assumed coverage of V2X with an Equal Weight rating and $74 price target. The firm, which is constructive on V2X's position as a defense pureplay, sees high revenue visibility, tailwinds from defense spending, and insulation from AI disruption. However, its Equal Weight rating reflects what it views as a balanced risk-reward.
